1LyMwl4

104 REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 SUPLEMENTO 2 / JUNIO 2015
31. Meljboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman
AH, Mulder BJ. Pregnancy and aortic root growth in the Marfan
syndrome a prospective study. Eur Heart J 2005;26:914-20.
32. Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE,
Fang J, et al. Characterizing the young patient with aortic dissection:
results from the International Registry of Aortic Dissection (IRAD).
J Am Coll Cardiol 2004;43:665-9.
33. Deanfield J, Thaulow E, Warnes C Chopra A, Seth S, Ramamurthy
S, et al. Management of grown up congenital heart disease. Eur
Heart J 2003;24:1035-84.
34. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy:
a retrospective study in a Dutch population. Eur J Obstet Gynecol
Reprod Biol 2001;98:28-35.
35. Immer FF, Bansi AG, Immer-Bansi AS, McDougall J, Zehr KJ,
Schaff HV, et al. Aortic dissection in pregnancy analysis of risk factors
and outcome. Ann Thorac Surg 2003;76:309-14.
36. European Society of Gynecology (ESG); Association for European
Paediatric Cardiology (AEPC); German Society for Gender Medicine
(DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C,
Cifkova R, Ferreira R, Foidart JM, et al. Task Force on the Management
of Cardiovascular Diseases During Pregnancy of the European
Society of Cardiology. Guidelines on the management of cardiovascular
diseases during pregnancy. Eur Heart J 2011;32:3147-97.
37. Therrien J, Gatzoulis M, Graham T, Bink-Boelkens M, Connelly
M, Niwa K, et al. Canadian Cardiovascular Society Consensus Conference
2001 update: recommendations for the management of adults
with congenital heart disease, part II. Can J Cardiol 2001;17:1029-50.
38. Elkayam U, Gleicher N. Hemodynamics and cardiac function
during normal pregnancy and the puerperium. En: Elkayam U,
Gleicher N, editors. Cardiac Problems in Pregnancy. New York, NY:
Wiley-Liss; 1998. p. 3-22.
39. Weiss Branko M, Von Segesser LK, Alon E, Seifert B, Turina
MI. Outcome of cardiovascular surgery and pregnancy: a systematic
review of the period 1984-96. Am J Obstet Gynecol 1998;179:1643-53.
40. Ben-Ami M, Battino S, Rosenfeld T, Mardin G, Shalev E. Aortic
valve replacement during pregnancy. A case report and review of the
literature. Acta Obstet Gynecol Scand 1990;69:651-3.
41. Khairy P, Ouyang DW, Fernandes SM, Lee Parvitz A, Economy
KE, Landberg MJ. Pregnancy outcomes in women with congenital
heart disease. Circulation 2006;111:517-24.
42. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant
women with mechanical heart valves. A systematic review of the
literature. Arch Intern Med 2000;160:191-6.
43. Elkayam U, Bitar F. Valvular heart disease and pregnancy. Part
II: Prosthetic valves. J Am Coll Cardiol 2005;46:403-10.
44. Meschengieser SS, Fondevila CG, Santarelli MT, Lazzari MA.
Anticoagulation in pregnant women with mechanical heart valve
prostheses. Heart 1999;82:23-6.
45. Vázquez Blanco M, Xavier D, Grosso O, Kaminker A, Brito V,
Rodriguez G, et al. Valve prostheses anticoagulation in pregnancy.
Cardiovasc Drugs Ther 2000;14:224.
46. Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tveit
A. Management of pregnant women with mechanical heart valve
prosthesis: thromboprophylaxis with low molecular weight heparin.
Thromb Res 2009;124:262-7.
47. Cotrufo M, De Feo M, De Santo LS, Romano G, Della Corte A,
Renzulli A, et al. Risk of warfarin during pregnancy with mechanical
valve prostheses. Obstet Gynecol 2002;99:35-40.
48. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M.
Dose dependent fetal complications of warfarin in pregnant women
with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
49. Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates
that dalteparin requirements increase in pregnancy to
maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol
2004;191:1024-9.
50. Friedrich E, Hameed AB. Fluctuations in anti-factor Xa levels
with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol
2010;30:253-7.